Literature DB >> 3624397

Gas chromatographic-mass spectrometric analysis and preliminary human pharmacokinetics of sertraline, a new antidepressant drug.

H G Fouda, R A Ronfeld, D J Weidler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3624397     DOI： 10.1016/0378-4347(87)80108-1

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  5 in total

Review 1.  Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  C L DeVane
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 2.  Clinical pharmacokinetics of sertraline.

Authors:  C Lindsay DeVane; Heidi L Liston; John S Markowitz
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.

Authors:  D Murdoch; D McTavish
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

4.  Development and validation of stability indicating method for determination of sertraline following ICH guidlines and its determination in pharmaceuticals and biological fluids.

Authors:  Mohamed I Walash; Fathallah F Belal; Nahed M El-Enany; Heba Elmansi
Journal:  Chem Cent J       Date:  2011-10-13       Impact factor: 4.215

5.  PharmGKB summary: sertraline pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Kevin Hicks; Laura B Ramsey; Jeffrey R Strawn; D Max Smith; Margarita Bobonis Babilonia; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.